We are live on
!
Find out more
IWC
Integrated Wealth Counsel Portfolio holdings
AUM
$46.5M
1-Year Est. Return
7.34%
This Fund
S&P 500
This Quarter
Est. Return
+2.05%
1 Year Est. Return
+7.34%
3 Year Est. Return
-8.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$47.5M
AUM Growth
+$4.03M
(+9.3%)
Cap. Flow
+$3.52M
Cap. Flow
% of AUM
7.42%
Top 10 Holdings %
Top 10 Hldgs %
70.19%
Holding
218
New
140
Increased
29
Reduced
12
Closed
1
Avg Time Held
3.3
quarters
Top 10 Avg Time Held
8.2
quarters
Top 20 Avg Time Held
7.2
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$854K |
| 2 |
Pfizer
PFE
|
+$582K |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$470K |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$314K |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$281K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares International Developed Real Estate ETF
IFGL
|
+$731K |
| 2 |
State Street SPDR Dow Jones International Real Estate ETF
RWX
|
+$692K |
| 3 |
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
|
+$615K |
| 4 |
Templeton Emerging Markets Income Fund
TEI
|
+$546K |
| 5 |
Saba Capital Income & Opportunities Fund II
SABA
|
+$483K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 66.93% |
| 2 | Financials | 7.98% |
| 3 | Healthcare | 5.37% |
| 4 | Energy | 4.59% |
| 5 | Technology | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Templeton Emerging Markets Income Fund
TEI
$292M
| $5.65M | 11.89% |
513,537
-50,005
| -9% | -$546K |
2016 Q1
2 quarters
|
|
|
2
State Street SPDR Dow Jones International Real Estate ETF
RWX
$242M
| $5.27M | 11.09% |
126,318
-16,465
| -12% | -$692K |
2013 Q2
13 quarters
|
|
|
3
Saba Capital Income & Opportunities Fund II
SABA
$207M
| $5.04M | 10.61% |
404,115
-37,792
| -9% | -$483K |
2016 Q1
2 quarters
|
|
|
4
iShares International Developed Real Estate ETF
IFGL
$75.7M
| $4.87M | 10.24% |
161,261
-24,250
| -13% | -$731K |
2013 Q2
13 quarters
|
|
|
5
DELISTED
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
| $4.54M | 9.55% |
159,854
-22,034
| -12% | -$615K |
2013 Q4
11 quarters
|
|
6
SPDR Gold Trust
GLD
$142B
| $2.61M | 5.5% |
20,805
-565
| -3% | -$72K |
2013 Q2
13 quarters
|
|
7
Ares Capital
ARCC
$13.3B
| $1.78M | 3.74% |
114,691
-9,630
| -8% | -$148K |
2013 Q2
13 quarters
|
|
|
8
Chevron
CVX
$416B
| $1.35M | 2.83% |
13,089
+8,367
| +177% | +$854K |
2013 Q2
13 quarters
|
|
9
MidCap Financial Investment
MFIC
$698M
| $1.27M | 2.68% |
73,269
-5,902
| -7% | -$103K |
2013 Q2
13 quarters
|
|
10
Apple
AAPL
$4.91T
| $977K | 2.06% |
34,564
-11,556
| -25% | -$306K |
2013 Q2
13 quarters
|
|
11
GE Aerospace
GE
$320B
| $894K | 1.88% |
6,296
+1,072
| +21% | +$160K |
2013 Q2
13 quarters
|
|
|
12
iShares MSCI Emerging Markets ETF
EEM
$31B
| $616K | 1.3% |
16,460
+7,680
| +87% | +$281K |
2013 Q2
13 quarters
|
|
13
iShares Mortgage Real Estate ETF
REM
$438M
| $579K | 1.22% |
13,770
-1,561
| -10% | -$66.2K |
2013 Q3
12 quarters
|
|
|
14
Pfizer
PFE
$161B
| $559K | 1.18% |
+17,410
| New | +$582K |
2016 Q3
0 quarters
|
|
|
15
iShares MSCI EAFE ETF
EFA
$76.4B
| $538K | 1.13% |
9,105
+5,420
| +147% | +$314K |
2013 Q2
13 quarters
|
|
16
3M
MMM
$82.5B
| $486K | 1.02% |
3,301
+86
| +3% | +$12.8K |
2013 Q2
13 quarters
|
|
17
ExxonMobil
XOM
$695B
| $486K | 1.02% |
5,565
+635
| +13% | +$56.3K |
2013 Q2
13 quarters
|
|
|
18
State Street SPDR S&P 500 ETF Trust
SPY
$833B
| $471K | 0.99% |
+2,176
| New | +$470K |
2016 Q3
0 quarters
|
|
19
Johnson & Johnson
JNJ
$630B
| $450K | 0.95% |
3,810
+1,275
| +50% | +$155K |
2013 Q2
13 quarters
|
|
20
Abbott
ABT
$172B
| $438K | 0.92% |
10,364
+484
| +5% | +$20.7K |
2013 Q2
13 quarters
|
|
21
Procter & Gamble
PG
$351B
| $424K | 0.89% |
4,721
+2,421
| +105% | +$210K |
2013 Q2
13 quarters
|
|
22
IBM
IBM
$214B
| $362K | 0.76% |
2,386
+547
| +30% | +$83K |
2013 Q2
13 quarters
|
|
23
AbbVie
ABBV
$489B
| $328K | 0.69% |
5,194
+314
| +6% | +$20.3K |
2013 Q2
13 quarters
|
|
24
JPMorgan Chase
JPM
$885B
| $290K | 0.61% |
4,361
+361
| +9% | +$23.5K |
2013 Q2
13 quarters
|
|
25
Gartner
IT
$12.1B
| $249K | 0.52% |
2,820
| – | – |
2014 Q2
9 quarters
|
|
Similar funds
BC
RCI
NAM
FNYS
JPC
OL
MNH
GI
Integrated Wealth Counsel's Q3 2016 Portfolio in Review
As of Q3 2016, Integrated Wealth Counsel held 218 positions worth $47.5M, up 9.3% from $43.5M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Integrated Wealth Counsel deployed $3.52M of net new capital in Q3 2016, opening 140 new positions and adding to 29 existing holdings. Its largest new stake was Pfizer: 17,410 shares worth $559K.
By sector, the portfolio is most concentrated in Miscellaneous at 67% of assets, down from 74% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares International Developed Real Estate ETF, an estimated $731K trimmed.
- Integrated Wealth Counsel's largest Q3 2016 buy was Pfizer: 17,410 shares worth $559K.
- Integrated Wealth Counsel added most to Chevron in Q3 2016, an estimated $854K increase.
- Integrated Wealth Counsel's biggest Q3 2016 reduction was iShares International Developed Real Estate ETF, cutting an estimated $731K.
- Integrated Wealth Counsel fully exited Alerian MLP ETF in Q3 2016, selling an estimated $17K.
- Integrated Wealth Counsel's ten largest holdings make up 70% of its $47.5M portfolio in Q3 2016.
- Integrated Wealth Counsel opened 140 new positions and closed 1 in Q3 2016.
- Integrated Wealth Counsel's portfolio value rose 9.3% quarter-over-quarter to $47.5M.
Based on Integrated Wealth Counsel's 13F filing for Q3 2016, filed 9 Nov 2016.